Publication | Closed Access

Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance

ThrombosisHypertensionStatin IntoleranceCardiovascular DiseaseHealth PolicyClinical TrialsPharmacotherapyClear-outcomes TrialPreventive CardiologyPublic HealthMedicineAtherosclerosisBempedoic AcidDyslipidemiaCoronary Artery Disease